Altered effector responses of H-Y transgenic CD8+ cells

International Immunology

Volumn 9, Issue 10, 1997, Pages 1423-1430

  Arsov, Ivica ^a   Vukmanović, Stanislav ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CD8; Effector; H Y; Transgene

Indexed keywords

ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; EFFECTOR CELL; EXOCYTOSIS; FEMALE; MALE; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECRETORY GRANULE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE RECEPTOR GENE; TRANSGENE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; ESTERASES; FEMALE; H-Y ANTIGEN; INTERFERON TYPE II; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, TRANSGENIC; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 0030818528     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.10.1423     Document Type: Article

References (39)

1. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depreatere, V., Nagata, S., Hengartner, H. and Goldstein, P. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
2. Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650.
3. Griffiths, G. M. 1995. The cell biology of CTL killing. Curr. Opin. Immunol. 7:343.
4. Griffiths, G. M. and Argon, Y. 1995. Structure and biogenesis of lytic granules. Curr. Top. Microbiol. Immunol. 198:39.
5. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
6. Teh, H. S., Kisielow, P., Scott, B., Kishi, H., Uematsu, Y., Bluthmann, H. and von Boehmer, H. 1988. Thymic major histocompatibility complex antigens and the αβ T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335:229.
7. + thymocytes. Nature 333:742.
8. + thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature 351:150.
9. Carlow, D. A., van Oers, N. S., Teh, S.-J. and Teh, H.-S. 1992. Deletion of antigen-specific immature thymocytes by dendritic cells requires LFA-1/ICAM interactions. J Immunol. 148:1595.
10. Rocha, B. and von Boehmer, H. 1991. Peripheral selection of the T cell repertoire. Science 251:1225.
11. Bassiri, H., Markmann, J. F., Desai, N. M., Kim, J. I., Teh, H. S. and Barker, C. F. 1993. Allograft rejection by T cell receptor transgenic mice. J. Surg. Res. 54:437.
12. Hurme, M., Hetherington, C. M., Chandler, P. R. and Simpson, E. 1978. Cytotoxic T-cell response to H-Y: mapping of the Ir genes. J. Exp. Med. 147:758.
13. von Boehmer, H., Turton, H. K. and Haas, W. 1979. The role of the left end ot the H-2b haplotype in the male-specific cytotoxic T-cell response. Eur. J. Immunol. 9:913.
14. von Boehmer, H. and Haas, W. 1979. Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen. J. Exp. Med. 150:1134.
15. Croft, M., Carter, L., Swain, S. L. and Dutton, R. W. 1994. Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715.
16. Borgulya, P., Kishi, H., Uematsu, Y. and von Boehmer, H. 1992. Exclusion and inclusion of α and β T cell receptor alleles. Cell 69:529.
17. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
18. Larsen, C. P., Ritchie, S. C., Pearson, T. C., Linsley, P. S. and Lowry, R. P. 1992. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J. Exp. Med. 176:1215.
19. Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P. and Hodes, R. J. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631.
20. Guerder, S., Carding, S. R. and Flavell, R. A. 1995. B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors. J. Immunol. 155:5167.
21. Lindsten, T., June, C. H., Ledbetter, J. A., Stella, G. and Thompson, C. B. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
22. b epitope is encoded by a novel mouse Y chromosome gene. Nat. Genet. 14:474.
23. + T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science 251:1228.
24. + T cells from β2-microglobulin-deficient (β2m-/-) mice to syngeneic β2m+/+ cells. J. Immunol. 154:6252.
25. Hollsberg, P., Weber, W. E. J., Dangond, F., Batra, V., Sette, A. and Hafler, D. A. 1995. Differential activation of proliferation and cytotoxicity in human T-cell mediated lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl Acad. Sci. USA 92:4036.
26. Valitutti, S., Muller, S., Dessing, M. and Lanzavecchia, A. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.
27. Gervois, N., Guilloux, Y., Diez, E. and Jotereau, F. 1996. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. J. Exp. Med. 183:2403.
28. + T lymphocyte effector responses. J. Immunol. 159:582.
29. Brossart, P. and Bevan, M. J. 1996. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide. J. Exp. Med. 183:2449.
30. Harlan, D. M., Hengartner, H., Huang, M. L., Kang, Y.-H., Abe, R., Moreadith, R. W., Pircher, H., Gray, G., Ohashi, P., Freeman, G. J., Nadler, L. M., June, C. H. and Aichele, P. 1994. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc. Natl Acad. Sci. USA 91:3137.
31. Soldevila, G., Geiger, T. and Flavell, R. A. 1995. Breaking immunologic ignorance to an antigenic peptide of Simian virus 40 large T antigen. J. Immunol. 155:5590.
32. Ramarathinam, L., Sarma, S., Maric, M., Zhao, M., Yang, G., Chen, L. and Liu, Y. 1995. Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected. J. Immunol. 155:5323.
33. Go, C., Lancki, D. W., Fitch, F. W. and Miller, J. 1993. Anergized T cell clones retain their cytolytic ability. J. Immunol. 150:367.
34. Fung-Leung, W.-P., Wallace, V. A., Gray, D., Sha, W. C., Pircher, H., Teh, H.-S., Loh, D. Y. and Mak, T. W. 1993. CD8 is needed for positive selection but differentially required for negative selection of T cells during thymic ontogeny. Eur. J. Immunol. 23:212.
35. Dutz, J. P., Teh, S. J., Killeen, N. and Teh, H. S. 1995. A mutation in the alpha 3 domain of Db that abrogates CD8 binding does not affect presentation of an immunodominant H-Y peptide. Immunology 85:74.
36. Gavin, M. A., Dere, B., Grandea, A. G., Hogquist, K. A. and Bevan, M. J. 1994. Major histocompatibility complex class I allele-specific peptide libraries: identification of peptides that mimic and H-Y T cell epitope. Eur J. Immunol. 24:2124.
37. + T cells by a self-derived peptide. Nature 378:295.
38. Esser, M. T., Krishnamurty, B. and Braciale, V. L. 1996. Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity. J. Exp. Med. 183:1697.
39. Wang, W., Meadows, L. R., den Haan, J. M. M., Sherman, N. E., Chen, Y., Blokland, E., Shabanowitz, J., Agulnik, A. I., Hendrickson, R. C., Bishop, C. E., Hunt, D. F., Goulmy, E. and Engelhard, V. H. 1995. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269:1588.